{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:58:01Z","timestamp":1767967081750,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Scientific Research (B)","award":["15H04687"],"award-info":[{"award-number":["15H04687"]}]},{"name":"Scientific Research (B)","award":["18H02580"],"award-info":[{"award-number":["18H02580"]}]},{"name":"Grant-in-Aid for Young Scientists (B)","award":["15K21273"],"award-info":[{"award-number":["15K21273"]}]},{"name":"Grant-in-Aid for Young Scientists (B)","award":["15K21271"],"award-info":[{"award-number":["15K21271"]}]},{"name":"Japanese SRF Grand for Biomedical Research","award":["1565"],"award-info":[{"award-number":["1565"]}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["201320161"],"award-info":[{"award-number":["201320161"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["201720339"],"award-info":[{"award-number":["201720339"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MEXT","award":["42890001"],"award-info":[{"award-number":["42890001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.neures.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T11:41:53Z","timestamp":1545651713000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immunoreactivity of a G protein-coupled l-DOPA receptor GPR143, in Lewy bodies"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-7051","authenticated-orcid":false,"given":"Yoshio","family":"Goshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motokazu","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Masukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2018.12.004_bib0005","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neures.2018.12.004_bib0010","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1242\/jcs.128561","article-title":"Expression of OA1 limits the fusion of a subset of MVBs with lysosomes\u2014a mechanism potentially involved in the initial biogenesis of melanosomes","volume":"126","author":"Burgoyne","year":"2013","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.neures.2018.12.004_bib0015","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/9.20.3011","article-title":"Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1","volume":"9","author":"d\u2019Addio","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neures.2018.12.004_bib0020","first-page":"35","article-title":"The Lewy body in Parkinson\u2019s disease","volume":"45","author":"Forno","year":"1987","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neures.2018.12.004_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainres.2015.01.020","article-title":"Expression of ocular albinism 1 (OA1), 3, 4-dihydroxy-l-phenylalanine (DOPA) receptor, in both neuronal and non-neuronal organs","volume":"1602","author":"Fukuda","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neures.2018.12.004_bib0030","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/hmg\/ddp415","article-title":"The ocular albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at early stages of melanogenesis to control melanosome identity and composition","volume":"18","author":"Giordano","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neures.2018.12.004_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1254\/jphs.14R03CR","article-title":"Cardiovascular actions of DOPA mediated by the gene product of ocular albinism 1","volume":"126","author":"Goshima","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neures.2018.12.004_bib0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bph.12459","article-title":"The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii","volume":"171","author":"Hiroshima","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neures.2018.12.004_bib0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","article-title":"An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin","volume":"105","author":"Imai","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.neures.2018.12.004_bib0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/hmg\/ddl439","article-title":"Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation","volume":"16","author":"Kitao","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neures.2018.12.004_bib0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tips.2017.05.006","article-title":"Folding underlies bidirectional role of GPR37\/Pael-R in Parkinson disease","volume":"38","author":"Leinartaite","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neures.2018.12.004_bib0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neures.2014.07.008","article-title":"Localization of ocular albinism-1 gene product GPR143 in the rat central nervous system","volume":"88","author":"Masukawa","year":"2014","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neures.2018.12.004_bib0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90903","article-title":"l-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptor","volume":"2","author":"Masukawa","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.neures.2018.12.004_bib0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-6147(93)90082-U","article-title":"Is l-dopa an endogenous neurotransmitter?","volume":"14","author":"Misu","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neures.2018.12.004_bib0075","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0165-6147(02)02013-8","article-title":"Is DOPA a neurotransmitter?","volume":"23","author":"Misu","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neures.2018.12.004_bib0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ana.20064","article-title":"Pael-R is accumulated in Lewy bodies of Parkinson\u2019s disease","volume":"55","author":"Murakami","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neures.2018.12.004_bib0085","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1242\/jcs.02930","article-title":"An unconventional dileucine-based motif and a novel cytosolic motif are required for the lysosomal and melanosomal targeting of OA1","volume":"119","author":"Piccirillo","year":"2006","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.neures.2018.12.004_bib0090","doi-asserted-by":"crossref","first-page":"e14020","DOI":"10.1371\/journal.pone.0014020","article-title":"Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of \u03b1-synucleinopathy\u2014implications for excitotoxicity","volume":"5","author":"Price","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neures.2018.12.004_bib0095","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.1073\/pnas.93.17.9055","article-title":"The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes","volume":"93","author":"Schiaffino","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2018.12.004_bib0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/12715","article-title":"Ocular albinism: evidence for a defect in an intracellular signal transduction system","volume":"23","author":"Schiaffino","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neures.2018.12.004_bib0105","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2018.12.004_bib0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neures.2018.12.004_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"alpha-Synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2018.12.004_bib0120","doi-asserted-by":"crossref","first-page":"e24376","DOI":"10.1371\/journal.pone.0024376","article-title":"Specific interaction of Galphai3 with the Oa1 G-protein coupled receptor controls the size and density of melanosomes in retinal pigment epithelium","volume":"6","author":"Young","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neures.2018.12.004_bib0125","doi-asserted-by":"crossref","first-page":"38510","DOI":"10.1038\/srep38510","article-title":"Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model","volume":"6","author":"Yedlapudi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neures.2018.12.004_bib0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1006\/bbrc.1997.6408","article-title":"A novel endothelin receptor type-B-like gene enriched in the brain","volume":"233","author":"Zeng","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neures.2018.12.004_bib0135","doi-asserted-by":"crossref","first-page":"44248","DOI":"10.1038\/srep44248","article-title":"Extracellular alpha-synuclein induces sphingosine 1-phosphate receptor subtype 1 uncoupled from inhibitory G-protein leaving beta-arrestin signal intact","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010218305984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010218305984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T18:37:17Z","timestamp":1569177437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010218305984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":27,"alternative-id":["S0168010218305984"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2018.12.004","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoreactivity of a G protein-coupled l-DOPA receptor GPR143, in Lewy bodies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}